Early Liver Dysfunction in Patients With Intra-Abdominal Infections

Kun Guo, Jianan Ren, Gefei Wang, Guosheng Gu, Guanwei Li, Xiuwen Wu, Jun Chen, Huajian Ren, Zhiwu Hong, Lei Wu, Guopu Chen, Deng Youming, Jieshou Li, Kun Guo, Jianan Ren, Gefei Wang, Guosheng Gu, Guanwei Li, Xiuwen Wu, Jun Chen, Huajian Ren, Zhiwu Hong, Lei Wu, Guopu Chen, Deng Youming, Jieshou Li

Abstract

Liver dysfunction is commonly seen in patients with severe sepsis; however, few studies were reported in intra-abdominal infections (IAIs). This study was performed to assess the risk factors for early liver dysfunction (ELD) in patients with IAIs and to determine the effects of ELD on outcomes of these patients.From January 2011 to November 2014, a retrospective study that screened 421 patients with IAIs was performed. ELD was defined as an increase in serum total bilirubin (TB) >2 mg/dL or aminotransferases levels greater than twice the normal value within 48 hours after IAIs' onset. Patients with pre-existing liver disease or major hepatobiliary injury were excluded. Risk factors for ELD and outcomes were compared by univariate and multivariate analyses. Subgroup analysis was performed for ELD patients within 24 to 48 hours.Of 353 enrolled patients admitted with IAIs, 147 (41.6%) developed ELD. Significant independent risk factors for ELD were trauma (odds ratio [OR] 1.770, 95% confidential interval [CI] 1.126-2.783, P = 0.01) and abdominal compartment syndrome (ACS) (OR 3.199, 95% CI 1.184-8.640, P = 0.02). Successful source control <24 hours was shown to exert protection against ELD after 24 hours during IAIs (OR 0.193, 95% CI 0.091-0.409, P < 0.001). ELD was associated with significantly worse outcomes, including longer ICU length of stay and higher in-hospital mortality. Multivariate analysis also showed that development of ELD was a predisposing factor of mortality in IAIs patients (P < 0.001).ELD was a common complication in patients with IAIs associated with worse outcomes. Trauma and ACS were relevant risk factors. Early successful source control appeared to be an important method to prevent and/or reduce ELD in patients with IAIs.

Conflict of interest statement

The authors report no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Flow of patients through the study.

References

    1. Harbrecht BG, Zenati MS, Doyle HR, et al. Hepatic dysfunction increases length of stay and risk of death after injury. J Trauma 2002; 53:517–523.
    1. Jager B, Drolz A, Michl B, et al. Jaundice increases the rate of complications and one-year mortality in patients with hypoxic hepatitis. Hepatology (Baltimore, Md) 2012; 56:2297–2304.
    1. Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013; 39:165–228.
    1. Blanco J, Muriel-Bombin A, Sagredo V, et al. Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study. Crit Care (London, England) 2008; 12:R158.
    1. Kobashi H, Toshimori J, Yamamoto K. Sepsis-associated liver injury: Incidence, classification and the clinical significance. Hepatol Res 2013; 43:255–266.
    1. Kramer L, Jordan B, Druml W, et al. Incidence and prognosis of early hepatic dysfunction in critically ill patients-a prospective multicenter study. Crit Care Med 2007; 35:1099–1104.
    1. Labori KJ, Bjornbeth BA, Raeder MG. Aetiology and prognostic implication of severe jaundice in surgical trauma patients. Scand J Gastroenterol 2003; 38:102–108.
    1. Nesseler N, Launey Y, Aninat C, et al. Clinical review: the liver in sepsis. Crit Care (London, England) 2012; 16:235.
    1. Grau T, Bonet A, Rubio M, et al. Liver dysfunction associated with artificial nutrition in critically ill patients. Crit Care (London, England) 2007; 11:R10.
    1. Kaffarnik MF, Lock JF, Vetter H, et al. Early diagnosis of sepsis-related hepatic dysfunction and its prognostic impact on survival: a prospective study with the LiMAx test. Crit Care (London, England) 2013; 17:R259.
    1. Brun-Buisson C, Meshaka P, Pinton P, et al. EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intens Care Med 2004; 30:580–588.
    1. Solomkin JS, Mazuski JE, Bradley JS, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 2010; 50:133–164.
    1. De Waele J, Lipman J, Sakr Y, et al. Abdominal infections in the intensive care unit: characteristics, treatment and determinants of outcome. BMC Infect Dis 2014; 14:420.
    1. te Boekhorst T, Urlus M, Doesburg W, et al. Etiologic factors of jaundice in severely ill patients. A retrospective study in patients admitted to an intensive care unit with severe trauma or with septic intra-abdominal complications following surgery and without evidence of bile duct obstruction. J Hepatol 1988; 7:111–117.
    1. Nishida T, Fujita N, Megawa T, et al. Postoperative hyperbilirubinemia after surgery for gastrointestinal perforation. Surg Today 2002; 32:679–684.
    1. Field E, Horst HM, Rubinfeld IS, et al. Hyperbilirubinemia: a risk factor for infection in the surgical intensive care unit. Am J Surg 2008; 195:304–306.discussion 306-307.
    1. Solomkin JS, Ristagno RL, Das AF, et al. Source control review in clinical trials of anti-infective agents in complicated intra-abdominal infections. Clin Infect Dis 2013; 56:1765–1773.
    1. Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013; 41:580–637.
    1. Kortgen A, Paxian M, Werth M, et al. Prospective assessment of hepatic function and mechanisms of dysfunction in the critically ill. Shock (Augusta, Ga ) 2009; 32:358–365.
    1. Recknagel P, Gonnert FA, Westermann M, et al. Liver dysfunction and phosphatidylinositol-3-kinase signalling in early sepsis: experimental studies in rodent models of peritonitis. PLoS Med 2012; 9:e1001338.
    1. Gonnert FA, Recknagel P, Hilger I, et al. Hepatic excretory function in sepsis: implications from biophotonic analysis of transcellular xenobiotic transport in a rodent model. Crit Care (London, England) 2013; 17:R67.
    1. Chand N, Sanyal AJ. Sepsis-induced cholestasis. Hepatology (Baltimore, Md ) 2007; 45:230–241.
    1. Wu Z, Han M, Chen T, et al. Acute liver failure: mechanisms of immune-mediated liver injury. Liver Int 2010; 30:782–794.
    1. Dahn MS, Mitchell RA, Lange MP, et al. Hepatic metabolic response to injury and sepsis. Surgery 1995; 117:520–530.
    1. Wang P, Hauptman JG, Chaudry IH. Hepatocellular dysfunction occurs early after hemorrhage and persists despite fluid resuscitation. J Surg Res 1990; 48:464–470.
    1. Champion HR, Jones RT, Trump BF, et al. Post-traumatic hepatic dysfunction as a major etiology in post-traumatic jaundice. J Trauma 1976; 16:650–657.
    1. Grau T, Bonet A. Caloric intake and liver dysfunction in critically ill patients. Curr Opin Clin Nutr Metab Care 2009; 12:175–179.
    1. Labori KJ, Raeder MG. Diagnostic approach to the patient with jaundice following trauma. Scand J Surg 2004; 93:176–183.
    1. Carr JA. Abdominal compartment syndrome: a decade of progress. J Am Coll Surg 2013; 216:135–146.
    1. Muftuoglu MA, Aktekin A, Ozdemir NC, et al. Liver injury in sepsis and abdominal compartment syndrome in rats. Surg Today 2006; 36:519–524.
    1. Cheatham ML. Abdominal compartment syndrome: pathophysiology and definitions. Scand J Trauma Resusc Emerg Med 2009; 17:10.
    1. Bauer M, Press AT, Trauner M. The liver in sepsis: patterns of response and injury. Curr Opin Crit Care 2013; 19:123–127.
    1. Jimenez MF, Marshall JC. Source control in the management of sepsis. Intensive Care Med 2001; 27 Suppl 1:S49–62.
    1. Kim JJ, Tsukamoto MM, Mathur AK, et al. Delayed paracentesis is associated with increased in-hospital mortality in patients with spontaneous bacterial peritonitis. Am J Gastroenterol 2014; 109:1436–1442.
    1. Marshall JC. Principles of source control in the early management of sepsis. Curr Infect Dis Rep 2010; 12:345–353.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する